CBP501 inhibits EGF-dependent cell migration, invasion and epithelial-to-mesenchymal transition of non-small cell lung cancer cells by blocking KRas to calmodulin binding.

CBP501 inhibits EGF-dependent cell migration, invasion and epithelial-to-mesenchymal transition of non-small cell lung cancer cells by blocking KRas to calmodulin binding. — المؤلف: Saito, Naoya — Oncotarget Sep 2017

المؤلف
Saito, Naoya
النشر
Oncotarget Sep 2017
الوصف
74006-74018 p.